Loading…

Perioperative immune function and pain control may underlie early hospital readmission and 90 day mortality following lung cancer resection: A prospective cohort study of 932 patients

Mortality following lung cancer resection has been shown to double between 30 and 90 days and readmission following surgery is associated with an increased risk of mortality. The aim of this study was to describe the causes of readmission and mortality and enable the identification of potentially mo...

Full description

Saved in:
Bibliographic Details
Published in:European journal of surgical oncology 2019-05, Vol.45 (5), p.863-869
Main Authors: Oswald, Nicola, Halle-Smith, James, Kerr, Amy, Webb, Joanne, Agostini, Paula, Bishay, Ehab, Kalkat, Maninder, Steyn, Richard, Naidu, Babu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c382t-d832039389a88b713a64cf666ad062f4e6d00d899e47a1261f43ecf9930b43673
cites cdi_FETCH-LOGICAL-c382t-d832039389a88b713a64cf666ad062f4e6d00d899e47a1261f43ecf9930b43673
container_end_page 869
container_issue 5
container_start_page 863
container_title European journal of surgical oncology
container_volume 45
creator Oswald, Nicola
Halle-Smith, James
Kerr, Amy
Webb, Joanne
Agostini, Paula
Bishay, Ehab
Kalkat, Maninder
Steyn, Richard
Naidu, Babu
description Mortality following lung cancer resection has been shown to double between 30 and 90 days and readmission following surgery is associated with an increased risk of mortality. The aim of this study was to describe the causes of readmission and mortality and enable the identification of potentially modifiable factors associated with these events. Prospective cohort study at a United Kingdom tertiary referral centre conducted over 55 months. Binary logistic regression was used to identify factors associated with death within 90 days of surgery. The 30 day and 90 day mortality rates were 1.4% and 3.3% respectively. The most common causes of death were pneumonia, lung cancer and Acute Respiratory Distress Syndrome/Multi Organ Failure. Potentially modifiable risk factors for death identified were: Postoperative pulmonary complications (Odds ratio 6.1), preoperative lymphocyte count (OR 0.25), readmission within 30 days (OR 4.2) and type of postoperative analgesia (OR for intrathecal morphine 4.8). The most common causes of readmission were pneumonia, shortness of breath and pain. Postoperative mortality is not simply due to fixed factors; the impacts of age, gender and surgical procedure on postoperative survival are reduced when the postoperative course of recovery is examined. Perioperative immune function, as portrayed by the occurrence of infection and lower lymphocyte count in the immediate perioperative period, and pain control method are strongly associated with 90 day mortality; further studies in these fields are indicated as are studies of psychological factors in recovery. ISRCTN00061628.
doi_str_mv 10.1016/j.ejso.2019.02.001
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2185562586</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0748798319302707</els_id><sourcerecordid>2185562586</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-d832039389a88b713a64cf666ad062f4e6d00d899e47a1261f43ecf9930b43673</originalsourceid><addsrcrecordid>eNp9Uc2OFCEYJEbjjqsv4MFw9NIjP900GC-bjX_JJnrQM2Hga5cJDS3Qa_rJfD0ZZ9ejFwihqr6qrxB6ScmeEireHPdwLGnPCFV7wvaE0EdoRwfOOkaH8THakbGX3agkv0DPSjkSQhQf1VN0wcmoBjX0O_T7K2SfFsim-jvAfp7XCHhao60-RWyiw4vxEdsUa04Bz2bDa3SQgwcMJocN36ay-GoCzmDc7Et5ICqCXYPPKbdfXzc8pRDSLx9_4LC2w5poITdagb_T3uIrvOSmdno2MzbdNioudXUbThNWnDUz1UOs5Tl6MplQ4MX9fYm-f3j_7fpTd_Pl4-frq5vOcslq5yRnhCsulZHyMFJuRG8nIYRxRLCpB-EIcVIp6EdDmaBTz8FOSnFy6LkY-SV6fdZtxn6uUKpuCS2EYCKktWhG5TAINkjRoOwMtS1DyTDpJfvZ5E1Tok-F6aM-FaZPhWnCdCuskV7d66-HGdw_ykNDDfDuDICW8s5D1sW2DVhwPrc9aZf8__T_AC3Iqso</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2185562586</pqid></control><display><type>article</type><title>Perioperative immune function and pain control may underlie early hospital readmission and 90 day mortality following lung cancer resection: A prospective cohort study of 932 patients</title><source>ScienceDirect Journals</source><creator>Oswald, Nicola ; Halle-Smith, James ; Kerr, Amy ; Webb, Joanne ; Agostini, Paula ; Bishay, Ehab ; Kalkat, Maninder ; Steyn, Richard ; Naidu, Babu</creator><creatorcontrib>Oswald, Nicola ; Halle-Smith, James ; Kerr, Amy ; Webb, Joanne ; Agostini, Paula ; Bishay, Ehab ; Kalkat, Maninder ; Steyn, Richard ; Naidu, Babu</creatorcontrib><description>Mortality following lung cancer resection has been shown to double between 30 and 90 days and readmission following surgery is associated with an increased risk of mortality. The aim of this study was to describe the causes of readmission and mortality and enable the identification of potentially modifiable factors associated with these events. Prospective cohort study at a United Kingdom tertiary referral centre conducted over 55 months. Binary logistic regression was used to identify factors associated with death within 90 days of surgery. The 30 day and 90 day mortality rates were 1.4% and 3.3% respectively. The most common causes of death were pneumonia, lung cancer and Acute Respiratory Distress Syndrome/Multi Organ Failure. Potentially modifiable risk factors for death identified were: Postoperative pulmonary complications (Odds ratio 6.1), preoperative lymphocyte count (OR 0.25), readmission within 30 days (OR 4.2) and type of postoperative analgesia (OR for intrathecal morphine 4.8). The most common causes of readmission were pneumonia, shortness of breath and pain. Postoperative mortality is not simply due to fixed factors; the impacts of age, gender and surgical procedure on postoperative survival are reduced when the postoperative course of recovery is examined. Perioperative immune function, as portrayed by the occurrence of infection and lower lymphocyte count in the immediate perioperative period, and pain control method are strongly associated with 90 day mortality; further studies in these fields are indicated as are studies of psychological factors in recovery. ISRCTN00061628.</description><identifier>ISSN: 0748-7983</identifier><identifier>EISSN: 1532-2157</identifier><identifier>DOI: 10.1016/j.ejso.2019.02.001</identifier><identifier>PMID: 30795954</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Lung cancer ; Mortality ; Outcomes ; Readmission ; Thoracic surgery</subject><ispartof>European journal of surgical oncology, 2019-05, Vol.45 (5), p.863-869</ispartof><rights>2019</rights><rights>Copyright © 2019. Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-d832039389a88b713a64cf666ad062f4e6d00d899e47a1261f43ecf9930b43673</citedby><cites>FETCH-LOGICAL-c382t-d832039389a88b713a64cf666ad062f4e6d00d899e47a1261f43ecf9930b43673</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30795954$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oswald, Nicola</creatorcontrib><creatorcontrib>Halle-Smith, James</creatorcontrib><creatorcontrib>Kerr, Amy</creatorcontrib><creatorcontrib>Webb, Joanne</creatorcontrib><creatorcontrib>Agostini, Paula</creatorcontrib><creatorcontrib>Bishay, Ehab</creatorcontrib><creatorcontrib>Kalkat, Maninder</creatorcontrib><creatorcontrib>Steyn, Richard</creatorcontrib><creatorcontrib>Naidu, Babu</creatorcontrib><title>Perioperative immune function and pain control may underlie early hospital readmission and 90 day mortality following lung cancer resection: A prospective cohort study of 932 patients</title><title>European journal of surgical oncology</title><addtitle>Eur J Surg Oncol</addtitle><description>Mortality following lung cancer resection has been shown to double between 30 and 90 days and readmission following surgery is associated with an increased risk of mortality. The aim of this study was to describe the causes of readmission and mortality and enable the identification of potentially modifiable factors associated with these events. Prospective cohort study at a United Kingdom tertiary referral centre conducted over 55 months. Binary logistic regression was used to identify factors associated with death within 90 days of surgery. The 30 day and 90 day mortality rates were 1.4% and 3.3% respectively. The most common causes of death were pneumonia, lung cancer and Acute Respiratory Distress Syndrome/Multi Organ Failure. Potentially modifiable risk factors for death identified were: Postoperative pulmonary complications (Odds ratio 6.1), preoperative lymphocyte count (OR 0.25), readmission within 30 days (OR 4.2) and type of postoperative analgesia (OR for intrathecal morphine 4.8). The most common causes of readmission were pneumonia, shortness of breath and pain. Postoperative mortality is not simply due to fixed factors; the impacts of age, gender and surgical procedure on postoperative survival are reduced when the postoperative course of recovery is examined. Perioperative immune function, as portrayed by the occurrence of infection and lower lymphocyte count in the immediate perioperative period, and pain control method are strongly associated with 90 day mortality; further studies in these fields are indicated as are studies of psychological factors in recovery. ISRCTN00061628.</description><subject>Lung cancer</subject><subject>Mortality</subject><subject>Outcomes</subject><subject>Readmission</subject><subject>Thoracic surgery</subject><issn>0748-7983</issn><issn>1532-2157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9Uc2OFCEYJEbjjqsv4MFw9NIjP900GC-bjX_JJnrQM2Hga5cJDS3Qa_rJfD0ZZ9ejFwihqr6qrxB6ScmeEireHPdwLGnPCFV7wvaE0EdoRwfOOkaH8THakbGX3agkv0DPSjkSQhQf1VN0wcmoBjX0O_T7K2SfFsim-jvAfp7XCHhao60-RWyiw4vxEdsUa04Bz2bDa3SQgwcMJocN36ay-GoCzmDc7Et5ICqCXYPPKbdfXzc8pRDSLx9_4LC2w5poITdagb_T3uIrvOSmdno2MzbdNioudXUbThNWnDUz1UOs5Tl6MplQ4MX9fYm-f3j_7fpTd_Pl4-frq5vOcslq5yRnhCsulZHyMFJuRG8nIYRxRLCpB-EIcVIp6EdDmaBTz8FOSnFy6LkY-SV6fdZtxn6uUKpuCS2EYCKktWhG5TAINkjRoOwMtS1DyTDpJfvZ5E1Tok-F6aM-FaZPhWnCdCuskV7d66-HGdw_ykNDDfDuDICW8s5D1sW2DVhwPrc9aZf8__T_AC3Iqso</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Oswald, Nicola</creator><creator>Halle-Smith, James</creator><creator>Kerr, Amy</creator><creator>Webb, Joanne</creator><creator>Agostini, Paula</creator><creator>Bishay, Ehab</creator><creator>Kalkat, Maninder</creator><creator>Steyn, Richard</creator><creator>Naidu, Babu</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190501</creationdate><title>Perioperative immune function and pain control may underlie early hospital readmission and 90 day mortality following lung cancer resection: A prospective cohort study of 932 patients</title><author>Oswald, Nicola ; Halle-Smith, James ; Kerr, Amy ; Webb, Joanne ; Agostini, Paula ; Bishay, Ehab ; Kalkat, Maninder ; Steyn, Richard ; Naidu, Babu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-d832039389a88b713a64cf666ad062f4e6d00d899e47a1261f43ecf9930b43673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Lung cancer</topic><topic>Mortality</topic><topic>Outcomes</topic><topic>Readmission</topic><topic>Thoracic surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oswald, Nicola</creatorcontrib><creatorcontrib>Halle-Smith, James</creatorcontrib><creatorcontrib>Kerr, Amy</creatorcontrib><creatorcontrib>Webb, Joanne</creatorcontrib><creatorcontrib>Agostini, Paula</creatorcontrib><creatorcontrib>Bishay, Ehab</creatorcontrib><creatorcontrib>Kalkat, Maninder</creatorcontrib><creatorcontrib>Steyn, Richard</creatorcontrib><creatorcontrib>Naidu, Babu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oswald, Nicola</au><au>Halle-Smith, James</au><au>Kerr, Amy</au><au>Webb, Joanne</au><au>Agostini, Paula</au><au>Bishay, Ehab</au><au>Kalkat, Maninder</au><au>Steyn, Richard</au><au>Naidu, Babu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Perioperative immune function and pain control may underlie early hospital readmission and 90 day mortality following lung cancer resection: A prospective cohort study of 932 patients</atitle><jtitle>European journal of surgical oncology</jtitle><addtitle>Eur J Surg Oncol</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>45</volume><issue>5</issue><spage>863</spage><epage>869</epage><pages>863-869</pages><issn>0748-7983</issn><eissn>1532-2157</eissn><abstract>Mortality following lung cancer resection has been shown to double between 30 and 90 days and readmission following surgery is associated with an increased risk of mortality. The aim of this study was to describe the causes of readmission and mortality and enable the identification of potentially modifiable factors associated with these events. Prospective cohort study at a United Kingdom tertiary referral centre conducted over 55 months. Binary logistic regression was used to identify factors associated with death within 90 days of surgery. The 30 day and 90 day mortality rates were 1.4% and 3.3% respectively. The most common causes of death were pneumonia, lung cancer and Acute Respiratory Distress Syndrome/Multi Organ Failure. Potentially modifiable risk factors for death identified were: Postoperative pulmonary complications (Odds ratio 6.1), preoperative lymphocyte count (OR 0.25), readmission within 30 days (OR 4.2) and type of postoperative analgesia (OR for intrathecal morphine 4.8). The most common causes of readmission were pneumonia, shortness of breath and pain. Postoperative mortality is not simply due to fixed factors; the impacts of age, gender and surgical procedure on postoperative survival are reduced when the postoperative course of recovery is examined. Perioperative immune function, as portrayed by the occurrence of infection and lower lymphocyte count in the immediate perioperative period, and pain control method are strongly associated with 90 day mortality; further studies in these fields are indicated as are studies of psychological factors in recovery. ISRCTN00061628.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>30795954</pmid><doi>10.1016/j.ejso.2019.02.001</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0748-7983
ispartof European journal of surgical oncology, 2019-05, Vol.45 (5), p.863-869
issn 0748-7983
1532-2157
language eng
recordid cdi_proquest_miscellaneous_2185562586
source ScienceDirect Journals
subjects Lung cancer
Mortality
Outcomes
Readmission
Thoracic surgery
title Perioperative immune function and pain control may underlie early hospital readmission and 90 day mortality following lung cancer resection: A prospective cohort study of 932 patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T00%3A42%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Perioperative%20immune%20function%20and%20pain%20control%20may%20underlie%20early%20hospital%20readmission%20and%2090%20day%20mortality%20following%20lung%20cancer%20resection:%20A%20prospective%20cohort%20study%20of%20932%20patients&rft.jtitle=European%20journal%20of%20surgical%20oncology&rft.au=Oswald,%20Nicola&rft.date=2019-05-01&rft.volume=45&rft.issue=5&rft.spage=863&rft.epage=869&rft.pages=863-869&rft.issn=0748-7983&rft.eissn=1532-2157&rft_id=info:doi/10.1016/j.ejso.2019.02.001&rft_dat=%3Cproquest_cross%3E2185562586%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c382t-d832039389a88b713a64cf666ad062f4e6d00d899e47a1261f43ecf9930b43673%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2185562586&rft_id=info:pmid/30795954&rfr_iscdi=true